Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J6II
|
|||
Former ID |
DCL000713
|
|||
Drug Name |
Azimilide
|
|||
Synonyms |
Azimilide [INN:BAN]; 1-({[5-(4-chlorophenyl)furan-2-yl]methylidene}amino)-3-[4-(4-methylpiperazin-1-yl)butyl]imidazolidine-2,4-dione
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Atrial fibrillation [ICD-11: BC81.3; ICD-10: I48] | Phase 3 | [1], [2] | |
Company |
Procter & Gamble
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H28ClN5O3
|
|||
Canonical SMILES |
CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl
|
|||
InChI |
1S/C23H28ClN5O3/c1-26-12-14-27(15-13-26)10-2-3-11-28-22(30)17-29(23(28)31)25-16-20-8-9-21(32-20)18-4-6-19(24)7-5-18/h4-9,16H,2-3,10-15,17H2,1H3/b25-16+
|
|||
InChIKey |
MREBEPTUUMTTIA-PCLIKHOPSA-N
|
|||
CAS Number |
CAS 149908-53-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
854022, 7978750, 14833668, 23996681, 44709202, 50064481, 50070831, 50363598, 57372898, 93300234, 103357886, 117470042, 126626730, 126657825, 126664981, 134339212, 135049470, 137048405, 142105729, 152099929, 163693485, 164788077, 175426919, 179149965, 223442513, 223659937, 226414227, 226414228, 249581702, 252345353
|
|||
ChEBI ID |
CHEBI:34545
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Potassium channel unspecific (KC) | Target Info | Modulator | [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2588). | |||
REF 2 | New antiarrhythmic agents for atrial fibrillation and atrial flutter. Expert Opin Emerg Drugs. 2005 May;10(2):311-22. | |||
REF 3 | Azimilide. Drugs. 2000 Feb;59(2):271-7; discussion 278-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.